
GSK and J&J back $1 billion biotech spin-off from Index Ventures
Tue Feb 2, 2016 5:12am EST
LONDON (Reuters) – Index Ventures, an early investor in technology hits like Skype and Dropbox, is spinning off its biotech portfolio into a new $1 billion (695 million pounds) business, with backing from drug giants GlaxoSmithKline GSK.L and Johnson & Johnson JNJ.N.